Shares of Orchid Pharma on Friday hit a 52-week high of Rs 435.45 on the NSE after the company reported a change in financial performance. The Chennai-based company recorded a net profit of ₹55.24 crore for 2022-23 compared to a net loss of 56.89 crore for 2021-22. The company’s shares on the NSE hit a higher than 5% for the second straight day.
